Delivery Order SPE2DB24D2100-SPE2DB25FBGMX
Award Date 9/22/25
Potential Completion Date 10/14/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,790.80 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of HYPERRAB 300 Unit/ML Vial 5ML, with completion targeted for October 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the contractor's pharmaceutical supply services to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $14,053.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials (5ML) on May 30, 2025, with an ultimate completion date of June 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded without set-aside designation and will be...
- The Defense Logistics Agency awarded a $21,373.10 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for HYPERRAB 300 Unit/ML Vial 5ML, with completion expected by October 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,079.06 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials, with an ultimate completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract issued on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for HYPERRAB 300 Unit/mL Vial 5mL at a ceiling value of $10,686.55 under a firm fixed price contract. This delivery order represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 24, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,744.80 on July 30, 2025, for the supply of HYPERRAB 300 Unit/mL vials (5mL) to support federal medical procurement needs. The award is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 20, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain division. This contract represents...
- The Defense Logistics Agency awarded a $17,908 delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Hyperrab 300 Unit/mL vials (5mL). This competitively awarded, non-set-aside contract reflects firm fixed pricing and is scheduled for completion by June 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency awarded a $4,158.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of HYPERRAB 300 Unit/mL vials. This non-set-aside contract is classified as a child award under a larger contract vehicle and specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $42,979.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials (5 mL) with an ultimate completion date of October 17, 2025. This is a non-set-aside, competitively awarded contract with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vials, with a ceiling value of $4,158.12. This is a firm fixed price delivery order with no set-aside designation, awarded on August 4, 2025, with an ultimate completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger contract vehicle and...